OXFORD, United Kingdom, Oct. 03, 2024 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted therapeutics in obesity-related disorders and myopathies announces the appointment of experienced pharma business development executive Dr. David Holbrook as an independent Non-Executive Director (NED), and world-renowned diabetologist and clinical triallist, Professor Rury Holman, to its Scientific…
Posted: 2024-10-03 07:00:00